EUVIMED · CrossrefZeitschrift
Human Mutation
ISSN 1059-7794 · Hindawi Limited
Neueste Artikel
Multiomics Analysis Reveals CTHRC1+ CAFs Drive Immunosuppressive Niches and Predict Immunotherapy Resistance in Gastric Cancer
Construction of a UBE2S‐ and Ferroptosis‐Based Prognostic Model for Hepatocellular Carcinoma and Validation of UBE2S‐Mediated Ferroptosis
ILF3 Regulates Cell Proliferation and Metastasis by Competitively Antagonizing the Interaction Between HMGCL and USP38 in Hepatocellular Carcinoma
Malignant Giant Cell Tumor of Bone: A Clinicopathological Analysis of 15 Cases
Integrated Genomic and Single‐Cell Analysis Reveals Heterogeneity, Prognosis, and Treatment Vulnerability in Urothelial Carcinoma
The Genetic Architecture of FUT2–FUT3 Variation and Variant Combinations Underlies the Relatively High Prevalence of the Le(a+b+) Phenotype in Thais
The Role of APOBEC3B in Cancer: Mechanisms, Clinical Challenges, and Therapeutic Opportunities
Telomere Dynamics in Congenital Heart Defects: Hidden Architects of Cardiogenesis?
Thrombophilia‐Related Gene Polymorphisms and Recurrent Miscarriages in Lebanese Population: A Case‐Control Study
Multiomics Biomarkers for Differential Diagnosis of Pleural Effusion: Integration of Proteomic Markers and Single‐Cell Transcriptomics
From Variant to Biomarker in NSCLC Immunotherapy Resistance: Multiomics Evidence Chains and Accountable AI Integration
Characterization of Copy Number Variants in Hereditary Cancer Patients Through NGS Shows a Distinctive PALB2 Contribution to the Diagnostic Yield
Determining the Quality of Functional Evidence for Coding Variants in CYP1B1 for Use in Variant Classification
Single‐Cell RNA Sequencing–Integrated Fibroblast Markers and Candidate Drug–Target Associations in Pancreatic Ductal Adenocarcinoma
Shining a Light on the Mechanisms of Drug Resistance to Anti‐PD‐1 Therapy in Non‐small Cell Lung Cancer
A New Wnt1 Mutant Rat Model of Osteogenesis Imperfecta and Its Application in AAV9‐Mediated Gene Therapy
A Spatially Constrained Fibroblast–Myeloid Program Associates With Immune Exclusion and Poor Prognosis in Lung Adenocarcinoma
In Silico Assessment of SYNGAP1 Missense Variant Pathogenicity
Multiomics Dissection of Early‐Onset Colorectal Cancer (EOCRC) Reveals an Immunosuppressive Microenvironment and Identifies FAT3 Mutation as a Biomarker of Hot‐Like Immune Features
Deubiquitination of ETV4 by USP7 Promotes NSCLC Tumorigenesis via MAPK7 Activation
A Combined Transcriptomic and Machine Learning Study Reveals PAX8 as a Promising Diagnostic Biomarker in Endometriosis
Periostin Safeguards EGFR‐Driven Genomic Instability and Sustains the Immune‐Suppressive Niche in Glioblastoma
Vimentin Regulates Alternative Polyadenylation and mTOR Signaling via ARVCF to Promote B Cell Lymphoma Progression
Exploring Monogenic, Polygenic, and Epigenetic Models of Common Variable Immunodeficiency
Adaptation of ACMG/AMP Guidelines for Clinical Classification of BMPR2 Variants in Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity in ClinVar
Integrative Transcriptomic and Machine Learning Analysis Identifies Key Senescence‐Associated Secretory Phenotype Genes Associated With Immune Dysregulation in Periodontitis
Integrated Genomic and Functional Characterization of Palmitoylation in Clear Cell Renal Cell Carcinoma
Whole Genome Sequencing of “Mutation‐Negative” Individuals With Cornelia de Lange Syndrome
Multiomic Landscape Uncovers TRMT112 as a Central Driver of HPV‐Positive Head and Neck Squamous Cell Carcinoma
Genome Sequencing of Rare Disease Patients Through the Korean Regional Rare Disease Diagnostic Support Program
Jahrgänge
2026 · 1312025 · 982024 · 382023 · 32022 · 2102021 · 1572020 · 2222019 · 2382018 · 2242017 · 2252016 · 1912015 · 1922014 · 2132013 · 2482012 · 2402011 · 2292010 · 2442009 · 2942008 · 2222007 · 1912006 · 2262005 · 2372004 · 2282003 · 2492002 · 2292001 · 2572000 · 3941999 · 3061998 · 4331997 · 3561996 · 3271995 · 1401994 · 1361993 · 1001992 · 87
EUVIMED